Neurocrine Biosciences
NBIX
#1633
Rank
S$13.15 B
Marketcap
$132.99
Share price
1.28%
Change (1 day)
-26.62%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): S$0.68 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are S$2.35 Billion. , an increase over its 2023 earnings that were of S$0.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 S$0.67 B64.57%
2023 S$0.40 B41.13%
2022 S$0.28 B73.74%
2021 S$0.16 B-8.82%
2020 S$0.18 B77.78%
2019 S$0.10 B49.83%
2018 S$68.7 M-142.57%
2017 -S$0.17 Billion-14.73%
2016 -S$0.19 Billion53.15%
2015 -S$0.13 Billion46.25%
2014 -S$84.5 Million29.66%
2013 -S$65.17 Million-3530.8%
2012 S$1.89 M-95.73%
2011 S$44.49 M
2009 -S$62.56 Million-45.38%
2008 -S$0.12 Billion-58.87%
2007 -S$0.28 Billion87.3%
2006 -S$0.15 Billion351.97%
2005 -S$32.89 Million-52.09%
2004 -S$68.66 Million-10.98%
2003 -S$77.12 Million
2001 -S$57.57 Million
1999 -S$25.97 Million108.32%
1998 -S$12.47 Million
1996 S$3.8 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$8.27 Million-101.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.04 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$35.34 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.63 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.87 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.57 B 2,065.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$29.14 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$54.79 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA